{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:04:42Z","timestamp":1789787082271,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["POIR.04.02.00\u201300-D023\/20"],"award-info":[{"award-number":["POIR.04.02.00\u201300-D023\/20"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2016\/21\/B\/NZ4\/03294"],"award-info":[{"award-number":["2016\/21\/B\/NZ4\/03294"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.biopha.2023.116102","type":"journal-article","created":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T01:32:20Z","timestamp":1703899940000},"page":"116102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Chicago sky blue 6B exerts neuroprotective and anti-inflammatory effects on focal cerebral ischemia"],"prefix":"10.1016","volume":"170","author":[{"given":"B.","family":"Pomierny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Krzy\u017canowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sk\u00f3rkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Jurczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Budziszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2023.116102_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36598-4","article-title":"Spatio-temporal overview of neuroinflammation in an experimental mouse stroke model","volume":"9","author":"Buscemi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.116102_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100527","article-title":"Adult astrocytes from reptiles are resistant to proinflammatory activation via sustaining Vav1 expression","volume":"296","author":"Du","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2023.116102_bib3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbr.2012.11.003","article-title":"Chicago sky blue 6B, a vesicular glutamate transporters inhibitor, attenuates methamphetamine-induced hyperactivity and behavioral sensitization in mice","volume":"239","author":"He","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.116102_bib4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/jcbfm.2010.194","article-title":"Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke","volume":"31","author":"In\u00e1cio","year":"2011","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2023.116102_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1516-2","article-title":"Neuroinflammation: friend and foe for ischemic stroke","volume":"16","author":"Jayaraj","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2023.116102_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114734","article-title":"Chicago sky blue 6B (CSB6B), an allosteric inhibitor of macrophage migration inhibitory factor (MIF), suppresses osteoclastogenesis and promotes osteogenesis through the inhibition of the NF-\u03baB signaling pathway","volume":"192","author":"Jin","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2023.116102_bib7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1189\/jlb.1109766","article-title":"Inflammatory mechanisms in ischemic stroke: role of inflammatory cells","volume":"87","author":"Jin","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2023.116102_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/00207454.2016.1211648","article-title":"Serum macrophage migration inhibitory factor levels are associated with infarct volumes and long-term outcomes in patients with acute ischemic stroke","volume":"127","author":"Li","year":"2017","journal-title":"Int. J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2023.116102_bib9","article-title":"Cytokine MIF enhances blood-brain barrier permeability: impact for therapy in ischemic stroke","volume":"8","author":"Liu","year":"2018","journal-title":"Sci. Rep."},{"issue":"659","key":"10.1016\/j.biopha.2023.116102_bib10","first-page":"19","article-title":"Pathological role of two chemokines RANTES and MIF in ischemic stroke","volume":"31","author":"Liu","year":"2017","journal-title":"FASEB J."},{"issue":"February 1989","key":"10.1016\/j.biopha.2023.116102_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.biopha.2023.116102_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s10020-020-00163-5","article-title":"Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer\u2019s disease","volume":"26","author":"Nasiri","year":"2020","journal-title":"Mol. Med."},{"issue":"SEP","key":"10.1016\/j.biopha.2023.116102_bib13","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3389\/fimmu.2019.02231","article-title":"Mimicry of central-peripheral immunity in alzheimer\u2019s disease and discovery of neurodegenerative roles in neutrophil","volume":"10","author":"Park","year":"2019","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.biopha.2023.116102_bib14","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.3390\/ijms22157816","article-title":"The slow-releasing and mitochondria-targeted hydrogen sulfide (H2s) delivery molecule ap39 induces brain tolerance to ischemia","volume":"22","author":"Pomierny","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2023.116102_bib15","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1111\/jcmm.17284","article-title":"Identification of optimal reference genes for gene expression studies in a focal cerebral ischaemia model\u2014Spatiotemporal effects","volume":"26","author":"Pomierny","year":"2022","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.biopha.2023.116102_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-023-03259-1","article-title":"Inhibition of Vesicular Glutamate Transporters (VGLUTs) with Chicago Sky Blue 6B before focal cerebral ischemia offers neuroprotection","volume":"60","author":"Pomierny","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.biopha.2023.116102_bib17","article-title":"Why certain dyes are useful for localizing the sentinel lymph node","volume":"43","author":"Tsopelas","year":"2002","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biopha.2023.116102_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuro.2014.03.004","article-title":"Perspectives on neuroinflammation and excitotoxicity: a neurotoxic conspiracy?","volume":"43","author":"Viviani","year":"2014","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.biopha.2023.116102_bib19","first-page":"571","article-title":"\u03b3\u03b4 T Cell in cerebral ischemic stroke: characteristic, immunity-inflammatory role, and therapy","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Neurol."},{"issue":"22","key":"10.1016\/j.biopha.2023.116102_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.128025","article-title":"The small molecule chicago sky blue promotes heart repair following myocardial infarction in mice","volume":"4","author":"Yifa","year":"2019","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.biopha.2023.116102_bib21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/FBP.0000000000000007","article-title":"The antinociceptive effects of intracerebroventricular administration of Chicago sky blue 6B, a vesicular glutamate transporter inhibitor","volume":"24","author":"Yu","year":"2013","journal-title":"Behav. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2023.116102_bib22","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/1440-1681.12647","article-title":"Inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity suppresses microglia-mediated inflammatory responses","volume":"43","author":"Zhang","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2023.116102_bib23","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41401-021-00753-x","article-title":"Discovery of novel MIF inhibitors that attenuate microglial inflammatory activation by structures-based virtual screening and in vitro bioassays","volume":"43","author":"Zhang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2023.116102_bib24","article-title":"Macrophage migration inhibitory factor (MIF) in CNS diseases: functional regulation and potential therapeutic indication","author":"Zhang","year":"2023","journal-title":"Fundam. Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.116102_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1750-3639.2012.00614.x","article-title":"Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models","volume":"23","author":"Zhou","year":"2013","journal-title":"Brain Pathol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223019005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223019005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:32:36Z","timestamp":1773966756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223019005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":25,"alternative-id":["S0753332223019005"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.116102","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chicago sky blue 6B exerts neuroprotective and anti-inflammatory effects on focal cerebral ischemia","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.116102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116102"}}